MDACC Study No:2012-0441 ( NCT No: Not Applicable Clinical Trial)
Title:Prospective Assessment of Correlative and Tissue Biomarkers in Glioma Patients
(The PROACTIVE-Glioma Program) - A biomarker-driven program for clinical trial development for newly diagnosed and recurrent glioma patients
Principal Investigator:John DeGroot
Treatment Agent: None
Study Status:Open
Study Description:The goal of this clinical research study is to collect blood and tumor tissues
for biomarker testing from patients with brain tumor. Biomarkers are found in
the blood and tissues and may be related to the body's reaction to the disease
and/or treatment.

Researchers will use these biomarkers to look for and understand factors that
may play a role in the development of brain tumor. Researchers also want to
learn about possible genetic changes that may be related to brain tumor.
Hide details for General InformationGeneral Information

Disease Group:Brain; CNS
Phase of Study:N/A
Treatment Agents: None
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:
Supported By:N/A
Return Visit:
Home Care:

Hide details for Study Contact InformationStudy Contact Information

Physician Name:John DeGroot
Dept:Neuro Oncology
For Clinical Trial Enrollment:713-792-2883
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults